<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Apothecon, et al.; Withdrawal of Approval of 103 New Drug Applications and 35 Abbreviated New Drug Applications; Correction</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Apothecon, et al.; Withdrawal of Approval of 103 New Drug Applications and 35 Abbreviated New Drug Applications; Correction</h1>
    <p class="timestamp">Published: 2023-12-19 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register on February 11, 2009. The document announced the withdrawal of approval of 103 new drug applications and 35 abbreviated new drug applications (ANDAs) from multiple applicants, withdrawn as of March 13, 2009. The document erroneously included ANDA 75-108. The correct ANDA is ANDA 76-108 for Amiodarone hydrochloride (HCl) injection, 50 milligrams (mg)/milliliter (mL), held by Hospira, Inc., 275 Nort...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2023-27859</p>
    <p><strong>Publication Date:</strong> 2023-12-19</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/12/19/2023-27859/apothecon-et-al-withdrawal-of-approval-of-103-new-drug-applications-and-35-abbreviated-new-drug">https://www.federalregister.gov/documents/2023/12/19/2023-27859/apothecon-et-al-withdrawal-of-approval-of-103-new-drug-applications-and-35-abbreviated-new-drug</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-27859</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
